{"transactions":[{"id":1545601,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":92148,"kind":"person","name":"Weisman Wayne","position":1,"cik":"0001602327","reported_name":"Weisman Wayne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-04-08T21:36:07.000Z","date":"2024-04-08","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":27229,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding and unvested option to purchase Shares granted under an Issuer equity plan (each, an \"Issuer Stock Option\") vested in full. At the Effective Time, each Issuer Stock Option with an exercise price that is less than the Offer Amount was cancelled and converted into the right to receive a cash payment equal to the product of (A) the excess, if any, of the Offer Amount over the exercise price payable per Share with respect to such Issuer Stock Option, multiplied by (B) the total number of Shares subject to such Issuer Stock Option immediately prior to the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding and unvested option to purchase Shares granted under an Issuer equity plan (each, an \"Issuer Stock Option\") vested in full. At the Effective Time, each Issuer Stock Option with an exercise price that is less than the Offer Amount was cancelled and converted into the right to receive a cash payment equal to the product of (A) the excess, if any, of the Offer Amount over the exercise price payable per Share with respect to such Issuer Stock Option, multiplied by (B) the total number of Shares subject to such Issuer Stock Option immediately prior to the Effective Time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding and unvested option to purchase Shares granted under an Issuer equity plan (each, an \"Issuer Stock Option\") vested in full. At the Effective Time, each Issuer Stock Option with an exercise price that is less than the Offer Amount was cancelled and converted into the right to receive a cash payment equal to the product of (A) the excess, if any, of the Offer Amount over the exercise price payable per Share with respect to such Issuer Stock Option, multiplied by (B) the total number of Shares subject to such Issuer Stock Option immediately prior to the Effective Time."}],"balance_after":0,"derivative":{"exercise_price":0.74,"underlying":"Common Stock","underlying_shares":27229},"source":{"system":"sec-edgar","filing":"0001104659-24-044898","document":"tm2411350-9_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1602327/000110465924044898/tm2411350-9_4seq1.xml","form_type":"4"}},{"id":1545600,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":92148,"kind":"person","name":"Weisman Wayne","position":1,"cik":"0001602327","reported_name":"Weisman Wayne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-04-08T21:36:07.000Z","date":"2024-04-08","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":118182,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding and unvested option to purchase Shares granted under an Issuer equity plan (each, an \"Issuer Stock Option\") vested in full. At the Effective Time, each Issuer Stock Option with an exercise price that is less than the Offer Amount was cancelled and converted into the right to receive a cash payment equal to the product of (A) the excess, if any, of the Offer Amount over the exercise price payable per Share with respect to such Issuer Stock Option, multiplied by (B) the total number of Shares subject to such Issuer Stock Option immediately prior to the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding and unvested option to purchase Shares granted under an Issuer equity plan (each, an \"Issuer Stock Option\") vested in full. At the Effective Time, each Issuer Stock Option with an exercise price that is less than the Offer Amount was cancelled and converted into the right to receive a cash payment equal to the product of (A) the excess, if any, of the Offer Amount over the exercise price payable per Share with respect to such Issuer Stock Option, multiplied by (B) the total number of Shares subject to such Issuer Stock Option immediately prior to the Effective Time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding and unvested option to purchase Shares granted under an Issuer equity plan (each, an \"Issuer Stock Option\") vested in full. At the Effective Time, each Issuer Stock Option with an exercise price that is less than the Offer Amount was cancelled and converted into the right to receive a cash payment equal to the product of (A) the excess, if any, of the Offer Amount over the exercise price payable per Share with respect to such Issuer Stock Option, multiplied by (B) the total number of Shares subject to such Issuer Stock Option immediately prior to the Effective Time."}],"balance_after":0,"derivative":{"exercise_price":0.8,"underlying":"Common Stock","underlying_shares":118182},"source":{"system":"sec-edgar","filing":"0001104659-24-044898","document":"tm2411350-9_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1602327/000110465924044898/tm2411350-9_4seq1.xml","form_type":"4"}},{"id":1545599,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":92148,"kind":"person","name":"Weisman Wayne","position":1,"cik":"0001602327","reported_name":"Weisman Wayne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-04-08T21:36:07.000Z","date":"2024-04-08","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":73620,"price":1.1,"value":80982.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted stock units granted under an Issuer equity plan (\"RSUs\") granted to the Reporting Person. Each RSU represented a contingent right to receive one Share upon vesting of the RSU. Pursuant to the terms of the Merger Agreement, each outstanding RSU that was outstanding and unvested immediately prior to the Effective Time vested in full. At the Effective Time, each RSU then outstanding was cancelled and converted into a cash payment equal to the product of (A) the total number of Shares then underlying such RSU multiplied by (B) the Offer Amount, without interest and subject to any withholding of taxes."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-24-044898","document":"tm2411350-9_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1602327/000110465924044898/tm2411350-9_4seq1.xml","form_type":"4"}},{"id":1545598,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":92148,"kind":"person","name":"Weisman Wayne","position":1,"cik":"0001602327","reported_name":"Weisman Wayne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-04-08T21:36:07.000Z","date":"2024-04-08","kind":"other","planned":false,"acquired":false,"shares":234982,"price":1.1,"value":258480.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the terms of that certain Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of February 28, 2024, by and among the Issuer, CoreRx, Inc., a Florida corporation (\"Parent\") and Cane Merger Sub, Inc., a Pennsylvania corporation and a wholly owned Subsidiary of Parent (\"Merger Sub\"), Merger Sub completed a tender offer for shares of common stock of the Issuer (each, a \"Share\") and thereafter merged with and into the Issuer, effective as of April 8, 2024 (the \"Effective Time\") with the Issuer surviving the merger. At the Effective Time, each issued and outstanding Share was cancelled and converted into the right to receive $1.10 per Share in cash (the \"Offer Amount\"), subject to any applicable withholding taxes and without interest."}],"balance_after":73620,"source":{"system":"sec-edgar","filing":"0001104659-24-044898","document":"tm2411350-9_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1602327/000110465924044898/tm2411350-9_4seq1.xml","form_type":"4"}},{"id":1795262,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":92148,"kind":"person","name":"Weisman Wayne","position":1,"cik":"0001602327","reported_name":"Weisman Wayne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-28T16:31:52.000Z","date":"2023-08-28","kind":"purchase","planned":false,"acquired":true,"shares":62500,"price":0.4,"value":25000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares acquired pursuant to an underwritten public offering of common stock by the Issuer."}],"balance_after":308602,"source":{"system":"sec-edgar","filing":"0001062993-23-017165","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1602327/000106299323017165/form4.xml","form_type":"4"}},{"id":1884569,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":92148,"kind":"person","name":"Weisman Wayne","position":1,"cik":"0001602327","reported_name":"Weisman Wayne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-05-19T16:54:52.000Z","date":"2023-05-17","kind":"grant","planned":false,"acquired":true,"shares":27229,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option will vest in full on May 17, 2024, subject to continued service with the Company."}],"balance_after":27229,"derivative":{"exercise_price":0.74,"expiration_date":"2033-05-17","underlying":"Common Stock","underlying_shares":27229},"source":{"system":"sec-edgar","filing":"0001062993-23-011842","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1602327/000106299323011842/form4.xml","form_type":"4"}},{"id":1884568,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":92148,"kind":"person","name":"Weisman Wayne","position":1,"cik":"0001602327","reported_name":"Weisman Wayne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-19T16:54:52.000Z","date":"2023-05-17","kind":"grant","planned":false,"acquired":true,"shares":73620,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These restricted stock units will vest in full on May 17, 2024, subject to continued service with the Company. Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":246102,"source":{"system":"sec-edgar","filing":"0001062993-23-011842","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1602327/000106299323011842/form4.xml","form_type":"4"}},{"id":2195772,"issuer":{"id":7620,"kind":"organization","name":"Lifeward Ltd.","symbol":"LFWD"},"owners":[{"id":92148,"kind":"person","name":"Weisman Wayne","position":1,"cik":"0001602327","reported_name":"Weisman Wayne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value NIS 0.25 per share","published_at":"2022-08-03T16:08:19.000Z","date":"2022-08-02","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"ESOP"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 50,000 ordinary shares, par value NIS 0.25 per share, issuable upon the vesting of restricted stock units (\"RSUs\") granted on August 2, 2022 under the ReWalk Robotics Ltd. Amended and Restated 2014 Incentive Compensation Plan. The RSUs vest ratably in four equal quarterly installments starting three months following the date of grant."}],"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001062993-22-017169","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1602327/000106299322017169/form4.xml","form_type":"4"}},{"id":2227800,"issuer":{"id":109081,"kind":"organization","name":"Baudax Bio, Inc.","symbol":"BXRX"},"owners":[{"id":92148,"kind":"person","name":"Weisman Wayne","position":1,"cik":"0001602327","reported_name":"Weisman Wayne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-17T16:10:12.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":39473,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") is the economic equivalent of one share of Baudax Bio, Inc. (the \"Company\") common stock, and may be settled, at the Company's option, in cash, shares of common stock, or a combination thereof. The RSUs vest in full on June 15, 2023, subject to continued service with the Company through the vesting date. Upon vesting, if settled in cash, each RSU will entitle the grantee to a cash-payment equal to the \"Fair Market Value\" (as defined in the Company's 2019 Equity Incentive Plan) of one share of the Company's common stock on the vesting date."}],"balance_after":42900,"source":{"system":"sec-edgar","filing":"0001062993-22-015122","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1602327/000106299322015122/form4.xml","form_type":"4"}},{"id":2261802,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":92148,"kind":"person","name":"Weisman Wayne","position":1,"cik":"0001602327","reported_name":"Weisman Wayne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-05-20T17:35:21.000Z","date":"2022-05-18","kind":"grant","acquired":true,"shares":118182,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option will vest in full on May 18, 2023, subject to continued service with the Company."}],"balance_after":118182,"derivative":{"exercise_price":0.8,"expiration_date":"2032-05-18","underlying":"Common Stock","underlying_shares":118182},"source":{"system":"sec-edgar","filing":"0001062993-22-013170","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1602327/000106299322013170/form4.xml","form_type":"4"}},{"id":2261801,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":92148,"kind":"person","name":"Weisman Wayne","position":1,"cik":"0001602327","reported_name":"Weisman Wayne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-20T17:35:21.000Z","date":"2022-05-18","kind":"grant","acquired":true,"shares":87500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These restricted stock units will vest in full on May 18, 2023, subject to continued service with the Company. Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":172482,"source":{"system":"sec-edgar","filing":"0001062993-22-013170","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1602327/000106299322013170/form4.xml","form_type":"4"}},{"id":2502825,"issuer":{"id":7620,"kind":"organization","name":"Lifeward Ltd.","symbol":"LFWD"},"owners":[{"id":92148,"kind":"person","name":"Weisman Wayne","position":1,"cik":"0001602327","reported_name":"Weisman Wayne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value NIS 0.25 per share","published_at":"2021-11-19T16:02:31.000Z","date":"2021-11-15","kind":"sale","acquired":false,"shares":4129,"price":1.53,"value":6317.37,"ownership":{"direct":false,"nature":"By Partnership"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The disposed of securities consist of 2,480 ordinary shares sold by Vitalife Partners (Overseas) L.P. (\"Vitalife Partners Overseas\"), 820 ordinary shares sold by Vitalife Partners (Israel) L.P. (\"Vitalife Partners Israel\") and 829 ordinary shares sold by Vitalife Partners (D.C.M) L.P. (\"Vitalife Partners D.C.M\"). The shares were disposed of in connection with the termination of the funds."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Based on filings made with the SEC, consists of 40,707 ordinary shares beneficially owned by SCP Vitalife Partners II, L.P. (\"SCP Vitalife Partners II\"), a limited partnership organized in the Cayman Islands, 13,596 ordinary shares beneficially owned by SCP Vitalife Partners (Israel) II, L.P. (\"SCP Vitalife Partners Israel II\"), a limited partnership organized in Israel and 1,571 ordinary shares held by the Israel Innovation Authority (the \"IIA\"), that Vitalife Partners Overseas, Vitalife Partners Israel and Vitalife Partners DCM have the right to acquire from IIA. The reporting person is therefore deemed to beneficially own 55,874 ordinary shares of the Company."}],"balance_after":86519,"source":{"system":"sec-edgar","filing":"0001178913-21-003654","document":"zk2126868.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1602327/000117891321003654/zk2126868.xml","form_type":"4"}},{"id":2693287,"issuer":{"id":7620,"kind":"organization","name":"Lifeward Ltd.","symbol":"LFWD"},"owners":[{"id":92148,"kind":"person","name":"Weisman Wayne","position":1,"cik":"0001602327","reported_name":"Weisman Wayne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value NIS 0.25 per share","published_at":"2021-05-27T17:18:33.000Z","date":"2021-05-21","kind":"grant","acquired":true,"shares":13888,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Partnership"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person is amending the Form 4 filed on May 24, 2021, which, due to an administrative error, inadvertently reported the grant on May 21, 2021 of 20,833 ordinary shares, par value NIS 0.25 per share (\"Ordinary Shares\"), issuable upon the vesting of restricted stock units (\"RSUs\") under the ReWalk Robotics Ltd. Amended and Restated 2014 Incentive Compensation Plan. The Reporting Person was actually granted 13,888 Ordinary Shares, issuable upon the vesting of RSUs. The RSUs vest in four equal quarterly instalments starting three months following the date of grant."},{"field":"shares","element":"transactionShares","label":"F2","text":"The Reporting Person immediately and automatically assigned these Ordinary Shares to SCP Vitalife II (\"SCP\") pursuant to the policies of SCP regarding Shares ownership by its employees, as documented by an Agreement between the Reporting Person and SCP. The Reporting Person is serving on the Board of the Issuer with the permission of SCP."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Based on filings made with the SEC, consists of 40,707 ordinary shares beneficially owned by SCP Vitalife Partners II, L.P. (\"SCP Vitalife Partners II\"), a limited partnership organized in the Cayman Islands, 13,596 ordinary shares beneficially owned by SCP Vitalife Partners (Israel) II, L.P. (\"SCP Vitalife Partners Israel II\"), a limited partnership organized in Israel, 2,480 ordinary shares beneficially owned by Vitalife Partners (Overseas) L.P. (\"Vitalife Partners Overseas\"), 820 ordinary shares beneficially owned by Vitalife Partners (Israel) L.P. (\"Vitalife Partners Israel\"), 829 ordinary shares beneficially owned by Vitalife Partners (D.C.M) L.P. (\"Vitalife Partners DCM\") and 1,571 ordinary shares held by the Israel Innovation Authority (the \"IIA\"), that Vitalife Partners Overseas, Vitalife Partners Israel and Vitalife Partners DCM have the right to acquire from IIA. The reporting person is therefore deemed to beneficially own 60,003 shares of the Company"}],"balance_after":90648,"source":{"system":"sec-edgar","filing":"0001178913-21-001947","document":"zk2126123.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1602327/000117891321001947/zk2126123.xml","form_type":"4/A","original_submission_date":"2021-05-24"}},{"id":2698902,"issuer":{"id":7620,"kind":"organization","name":"Lifeward Ltd.","symbol":"LFWD"},"owners":[{"id":92148,"kind":"person","name":"Weisman Wayne","position":1,"cik":"0001602327","reported_name":"Weisman Wayne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value NIS 0.25 per share","published_at":"2021-05-24T17:25:22.000Z","date":"2021-05-21","kind":"grant","acquired":true,"shares":20833,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Partnership"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 20,833 ordinary shares, par value NIS 0.25 per share (\"Ordinary Shares\"), issuable upon the vesting of restricted stock units (\"RSUs\") granted on May 21, 2021 under the ReWalk Robotics Ltd. Amended and Restated 2014 Incentive Compensation Plan. The RSUs vest in four equal quarterly installments starting three months following the date of grant."},{"field":"shares","element":"transactionShares","label":"F2","text":"The Reporting Person immediately and automatically assigned these Ordinary Shares to SCP Vitalife II (\"SCP\") pursuant to the policies of SCP regarding Shares ownership by its employees, as documented by an Agreement between the Reporting Person and SCP. The Reporting Person is serving on the Board of the Issuer with the permission of SCP."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Based on filings made with the SEC, consists of 40,707 ordinary shares beneficially owned by SCP Vitalife Partners II, L.P. (\"SCP Vitalife Partners II\"), a limited partnership organized in the Cayman Islands, 13,596 ordinary shares beneficially owned by SCP Vitalife Partners (Israel) II, L.P. (\"SCP Vitalife Partners Israel II\"), a limited partnership organized in Israel, 2,480 ordinary shares beneficially owned by Vitalife Partners (Overseas) L.P. (\"Vitalife Partners Overseas\"), 820 ordinary shares beneficially owned by Vitalife Partners (Israel) L.P. (\"Vitalife Partners Israel\"), 829 ordinary shares beneficially owned by Vitalife Partners (D.C.M) L.P. (\"Vitalife Partners DCM\") and 1,571 ordinary shares held by the Israel Innovation Authority (the \"IIA\"), that Vitalife Partners Overseas, Vitalife Partners Israel and Vitalife Partners DCM have the right to acquire from IIA. The reporting person is therefore deemed to beneficially own 60,003 shares of the Company"}],"balance_after":97593,"source":{"system":"sec-edgar","filing":"0001178913-21-001854","document":"zk2126087.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1602327/000117891321001854/zk2126087.xml","form_type":"4"}},{"id":2710306,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":92148,"kind":"person","name":"Weisman Wayne","position":1,"cik":"0001602327","reported_name":"Weisman Wayne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-05-17T16:09:37.000Z","date":"2021-04-20","kind":"grant","acquired":true,"shares":38012,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This amended Form 4 is being filed to correct a typographical error in the exercise price of the stock options acquired on April 20, 2021 as reported on the Form 4 filed on April 22, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option will vest on April 20, 2022."}],"balance_after":38012,"derivative":{"exercise_price":2.6,"expiration_date":"2031-04-20","underlying":"Common Stock","underlying_shares":38012},"source":{"system":"sec-edgar","filing":"0001192482-21-000436","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1602327/000119248221000436/edgar.xml","form_type":"4/A","original_submission_date":"2021-04-22"}},{"id":2741994,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":92148,"kind":"person","name":"Weisman Wayne","position":1,"cik":"0001602327","reported_name":"Weisman Wayne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-04-22T17:58:44.000Z","date":"2021-04-20","kind":"grant","acquired":true,"shares":38012,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option will vest on April 20, 2022."}],"balance_after":38012,"derivative":{"exercise_price":1.71,"expiration_date":"2031-04-20","underlying":"Common Stock","underlying_shares":38012},"source":{"system":"sec-edgar","filing":"0001192482-21-000352","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1602327/000119248221000352/edgar.xml","form_type":"4"}},{"id":2741993,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":92148,"kind":"person","name":"Weisman Wayne","position":1,"cik":"0001602327","reported_name":"Weisman Wayne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-22T17:58:44.000Z","date":"2021-04-20","kind":"grant","acquired":true,"shares":26923,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"All shares of common stock are represented by unvested restricted stock units that will vest on April 20, 2022. Vested shares will be delivered to the reporting person within 30 days following the vesting date."}],"balance_after":84982,"source":{"system":"sec-edgar","filing":"0001192482-21-000352","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1602327/000119248221000352/edgar.xml","form_type":"4"}},{"id":2752927,"issuer":{"id":109081,"kind":"organization","name":"Baudax Bio, Inc.","symbol":"BXRX"},"owners":[{"id":92148,"kind":"person","name":"Weisman Wayne","position":1,"cik":"0001602327","reported_name":"Weisman Wayne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-04-08T19:12:16.000Z","date":"2021-04-07","kind":"grant","acquired":true,"shares":83333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option will vest on April 7, 2022."}],"balance_after":83333,"derivative":{"exercise_price":1.24,"expiration_date":"2031-04-07","underlying":"Common Stock","underlying_shares":83333},"source":{"system":"sec-edgar","filing":"0001192482-21-000331","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1602327/000119248221000331/edgar.xml","form_type":"4"}},{"id":2752926,"issuer":{"id":109081,"kind":"organization","name":"Baudax Bio, Inc.","symbol":"BXRX"},"owners":[{"id":92148,"kind":"person","name":"Weisman Wayne","position":1,"cik":"0001602327","reported_name":"Weisman Wayne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-08T19:12:16.000Z","date":"2021-04-07","kind":"grant","acquired":true,"shares":56452,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"All shares of common stock are represented by unvested restricted stock units that will vest on April 7, 2022. Vested shares will be delivered to the reporting person within 30 days following the vesting date."}],"balance_after":119985,"source":{"system":"sec-edgar","filing":"0001192482-21-000331","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1602327/000119248221000331/edgar.xml","form_type":"4"}},{"id":3087500,"issuer":{"id":7620,"kind":"organization","name":"Lifeward Ltd.","symbol":"LFWD"},"owners":[{"id":92148,"kind":"person","name":"Weisman Wayne","position":1,"cik":"0001602327","reported_name":"Weisman Wayne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value NIS 0.25 per share","published_at":"2020-07-07T17:15:23.000Z","date":"2020-07-02","kind":"grant","acquired":true,"shares":10948,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Partnership"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 10,948 ordinary shares, par value NIS 0.25 per share (\"Ordinary Shares\"), issuable upon the vesting of restricted stock units (\"RSUs\") granted on July 2, 2020 under the ReWalk Robotics Ltd. Amended and Restated 2014 Incentive Compensation Plan. The RSUs vest in four equal quarterly installments starting three months following the date of grant."},{"field":"shares","element":"transactionShares","label":"F2","text":"The Reporting Person immediately and automatically assigned these Ordinary Shares to SCP Vitalife II (\"SCP\") pursuant to the policies of SCP regarding Shares ownership by its employees, as documented by an Agreement between the Reporting Person and SCP. The Reporting Person is serving on the Board of the Issuer with the permission of SCP."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Reflects our one-for-twenty-five reverse share split that became effective on April 1, 2019"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Based on filings made with the SEC, consists of 40,707 ordinary shares beneficially owned by SCP Vitalife Partners II, L.P. (\"SCP Vitalife Partners II\"), a limited partnership organized in the Cayman Islands, 13,596 ordinary shares beneficially owned by SCP Vitalife Partners (Israel) II, L.P. (\"SCP Vitalife Partners Israel II\"), a limited partnership organized in Israel, 2,480 ordinary shares beneficially owned by Vitalife Partners (Overseas) L.P. (\"Vitalife Partners Overseas\"), 820 ordinary shares beneficially owned by Vitalife Partners (Israel) L.P. (\"Vitalife Partners Israel\"), 829 ordinary shares beneficially owned by Vitalife Partners (D.C.M) L.P. (\"Vitalife Partners DCM\") and 1,571 ordinary shares held by the Israel Innovation Authority (the \"IIA\"), that Vitalife Partners Overseas, Vitalife Partners Israel and Vitalife Partners DCM have the right to acquire from IIA. The reporting person is therefore deemed to beneficially own 60,003 shares of the Company"}],"balance_after":76760,"source":{"system":"sec-edgar","filing":"0001178913-20-001995","document":"zk2024594.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1602327/000117891320001995/zk2024594.xml","form_type":"4"}},{"id":3154462,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":92148,"kind":"person","name":"Weisman Wayne","position":1,"cik":"0001602327","reported_name":"Weisman Wayne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-05-11T17:06:25.000Z","date":"2020-05-07","kind":"grant","acquired":true,"shares":12405,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option will vest on May 7, 2021."}],"balance_after":12405,"derivative":{"exercise_price":8.37,"expiration_date":"2030-05-07","underlying":"Common Stock","underlying_shares":12405},"source":{"system":"sec-edgar","filing":"0001192482-20-000340","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1602327/000119248220000340/edgar.xml","form_type":"4"}},{"id":3154461,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":92148,"kind":"person","name":"Weisman Wayne","position":1,"cik":"0001602327","reported_name":"Weisman Wayne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-11T17:06:25.000Z","date":"2020-05-07","kind":"grant","acquired":true,"shares":8363,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"All shares of common stock are represented by unvested restricted stock units that will vest on May 7, 2021. Vested shares will be delivered to the reporting person within 30 days following the vesting date."}],"balance_after":58059,"source":{"system":"sec-edgar","filing":"0001192482-20-000340","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1602327/000119248220000340/edgar.xml","form_type":"4"}},{"id":3156428,"issuer":{"id":109081,"kind":"organization","name":"Baudax Bio, Inc.","symbol":"BXRX"},"owners":[{"id":92148,"kind":"person","name":"Weisman Wayne","position":1,"cik":"0001602327","reported_name":"Weisman Wayne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-05-08T20:21:05.000Z","date":"2020-05-06","kind":"grant","acquired":true,"shares":34574,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option will vest on May 6, 2021."}],"balance_after":34574,"derivative":{"exercise_price":3.05,"expiration_date":"2030-05-06","underlying":"Common Stock","underlying_shares":34574},"source":{"system":"sec-edgar","filing":"0001192482-20-000335","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1602327/000119248220000335/edgar.xml","form_type":"4"}},{"id":3156427,"issuer":{"id":109081,"kind":"organization","name":"Baudax Bio, Inc.","symbol":"BXRX"},"owners":[{"id":92148,"kind":"person","name":"Weisman Wayne","position":1,"cik":"0001602327","reported_name":"Weisman Wayne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-08T20:21:05.000Z","date":"2020-05-06","kind":"grant","acquired":true,"shares":22951,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"All shares of common stock are represented by unvested restricted stock units that will vest on May 6, 2021. Vested shares will be delivered to the reporting person within 30 days following the vesting date."}],"balance_after":63533,"source":{"system":"sec-edgar","filing":"0001192482-20-000335","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1602327/000119248220000335/edgar.xml","form_type":"4"}},{"id":3193193,"issuer":{"id":109081,"kind":"organization","name":"Baudax Bio, Inc.","symbol":"BXRX"},"owners":[{"id":92148,"kind":"person","name":"Weisman Wayne","position":1,"cik":"0001602327","reported_name":"Weisman Wayne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-27T15:53:27.000Z","date":"2020-03-26","kind":"purchase","acquired":true,"shares":10000,"price":2.29,"value":22900.0,"ownership":{"direct":true},"balance_after":40582,"source":{"system":"sec-edgar","filing":"0001192482-20-000260","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1602327/000119248220000260/edgar.xml","form_type":"4"}},{"id":3348151,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":92148,"kind":"person","name":"Weisman Wayne","position":1,"cik":"0001602327","reported_name":"Weisman Wayne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-12-09T18:28:25.000Z","date":"2019-12-05","kind":"grant","acquired":true,"shares":15284,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units will vest in full on the earlier of (i) a change of control of Recro Pharma, Inc. (the \"Company\") (as defined in the Company's 2018 Amended and Restated Equity Incentive Plan) or (ii) December 5, 2020, subject to continued service with the Company."}],"balance_after":49696,"source":{"system":"sec-edgar","filing":"0001192482-19-000490","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1602327/000119248219000490/edgar.xml","form_type":"4"}},{"id":3348233,"issuer":{"id":109081,"kind":"organization","name":"Baudax Bio, Inc.","symbol":"BXRX"},"owners":[{"id":92148,"kind":"person","name":"Weisman Wayne","position":1,"cik":"0001602327","reported_name":"Weisman Wayne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-12-09T18:23:30.000Z","date":"2019-12-05","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units are scheduled to vest 50% each on December 5, 2020 and December 5, 2021, subject to continued service through the applicable vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Total includes common stock acquired pursuant to a special dividend issued on November 21, 2019, whereby all holders of common stock of Recro Pharma, Inc., as of November 15, 2019, received a dividend of one (1) share of Baudax Bio, Inc. common stock for every two and one-half (2.5) shares of Recro Pharma, Inc. common stock."}],"balance_after":30582,"source":{"system":"sec-edgar","filing":"0001192482-19-000484","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1602327/000119248219000484/edgar.xml","form_type":"4"}},{"id":3531576,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":92148,"kind":"person","name":"Weisman Wayne","position":1,"cik":"0001602327","reported_name":"Weisman Wayne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-05-10T16:26:11.000Z","date":"2019-05-09","kind":"grant","acquired":true,"shares":10888,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option will vest on May 9, 2020."}],"balance_after":10888,"derivative":{"exercise_price":8.8,"expiration_date":"2029-05-09","underlying":"Common Stock","underlying_shares":10888},"source":{"system":"sec-edgar","filing":"0001192482-19-000245","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1602327/000119248219000245/edgar.xml","form_type":"4"}},{"id":3531575,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":92148,"kind":"person","name":"Weisman Wayne","position":1,"cik":"0001602327","reported_name":"Weisman Wayne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-10T16:26:11.000Z","date":"2019-05-09","kind":"grant","acquired":true,"shares":7955,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"All shares of common stock are represented by unvested restricted stock units that will vest on May 9, 2020. Vested shares will be delivered to the reporting person within 30 days following the vesting date."}],"balance_after":34412,"source":{"system":"sec-edgar","filing":"0001192482-19-000245","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1602327/000119248219000245/edgar.xml","form_type":"4"}},{"id":3575213,"issuer":{"id":7620,"kind":"organization","name":"Lifeward Ltd.","symbol":"LFWD"},"owners":[{"id":92148,"kind":"person","name":"Weisman Wayne","position":1,"cik":"0001602327","reported_name":"Weisman Wayne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value NIS 0.01 per share","published_at":"2019-03-28T07:17:57.000Z","date":"2019-03-27","kind":"grant","acquired":true,"shares":116496,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"ESOP"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 116,496 ordinary shares, par value NIS 0.01 per share (\"Ordinary Shares\"), issuable upon the vesting of restricted stock units (\"RSUs\") granted on March 27, 2019 under the ReWalk 2014 Equity Incentive Plan. The RSUs vest in four equal quarterly installments starting three months following the date of grant."},{"field":"shares","element":"transactionShares","label":"F2","text":"The Reporting Person immediately and automatically assigned these Ordinary Shares to SCP Vitalife II (\"SCP\") pursuant to the policies of SCP regarding Shares ownership by its employees, as documented by an Agreement between the Reporting Person and SCP. The Reporting Person is serving on the Board of the Issuer with the permission of SCP."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Pursuant to the terms of the ReWalk 2014 Incentive Compensation Plan permitting the board of directors of ReWalk Robotics Ltd. (the ?Company?) to adjust the number of shares underlying equity awards in connection with stock splits, reverse stock splits or similar corporate events, the number of Ordinary Shares underlying the RSUs is subject to adjustment in connection with the Company?s planned reverse stock split, which the Company intends to effect shortly following its receipt of shareholder approval for such split on March 27, 2019."}],"balance_after":145245,"source":{"system":"sec-edgar","filing":"0001213900-19-005036","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1602327/000121390019005036/doc4.xml","form_type":"4"}},{"id":3934772,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":92148,"kind":"person","name":"Weisman Wayne","position":1,"cik":"0001602327","reported_name":"Weisman Wayne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-05-14T16:54:01.000Z","date":"2018-05-12","kind":"exercise","acquired":false,"shares":13274,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On May 12, 2017, the reporting person was granted 13,274 restricted stock units, vesting on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On May 12, 2017, the reporting person was granted 13,274 restricted stock units, vesting on the first anniversary of the grant date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":13274},"source":{"system":"sec-edgar","filing":"0001192482-18-000207","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1602327/000119248218000207/edgar.xml","form_type":"4"}},{"id":3934771,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":92148,"kind":"person","name":"Weisman Wayne","position":1,"cik":"0001602327","reported_name":"Weisman Wayne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-14T16:54:01.000Z","date":"2018-05-12","kind":"exercise","acquired":true,"shares":13274,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":26457,"source":{"system":"sec-edgar","filing":"0001192482-18-000207","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1602327/000119248218000207/edgar.xml","form_type":"4"}},{"id":3938991,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":92148,"kind":"person","name":"Weisman Wayne","position":1,"cik":"0001602327","reported_name":"Weisman Wayne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-05-10T18:56:59.000Z","date":"2018-05-04","kind":"grant","acquired":true,"shares":8965,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This amended Form 4 is being filed to correct a typographical error in the number of stock options acquired on May 4, 2018 as reported on the Form 4 filed on May 8, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option will vest on May 4, 2019."}],"balance_after":8965,"derivative":{"exercise_price":11.32,"expiration_date":"2028-05-04","underlying":"Common Stock","underlying_shares":8965},"source":{"system":"sec-edgar","filing":"0001192482-18-000194","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1602327/000119248218000194/edgar.xml","form_type":"4/A","original_submission_date":"2018-05-08"}},{"id":3942575,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":92148,"kind":"person","name":"Weisman Wayne","position":1,"cik":"0001602327","reported_name":"Weisman Wayne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-05-08T17:24:32.000Z","date":"2018-05-04","kind":"grant","acquired":true,"shares":5742,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option will vest on May 4, 2019."}],"balance_after":5742,"derivative":{"exercise_price":11.32,"expiration_date":"2028-05-04","underlying":"Common Stock","underlying_shares":5742},"source":{"system":"sec-edgar","filing":"0001192482-18-000181","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1602327/000119248218000181/edgar.xml","form_type":"4"}},{"id":3942574,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":92148,"kind":"person","name":"Weisman Wayne","position":1,"cik":"0001602327","reported_name":"Weisman Wayne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-08T17:24:32.000Z","date":"2018-05-04","kind":"grant","acquired":true,"shares":6183,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"All shares of common stock are represented by unvested restricted stock units that will vest on May 4, 2019. Vested shares will be delivered to the reporting person within 30 days following the vesting date."}],"balance_after":13183,"source":{"system":"sec-edgar","filing":"0001192482-18-000181","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1602327/000119248218000181/edgar.xml","form_type":"4"}},{"id":3949764,"issuer":{"id":7620,"kind":"organization","name":"Lifeward Ltd.","symbol":"LFWD"},"owners":[{"id":92148,"kind":"person","name":"Weisman Wayne","position":1,"cik":"0001602327","reported_name":"Weisman Wayne","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares, par value NIS 0.01 per share","published_at":"2018-05-02T16:02:45.000Z","date":"2018-04-30","kind":"grant","acquired":true,"shares":22727,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"ESOP"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 22,727 ordinary shares, par value NIS 0.01 per share (\"Ordinary Shares\"), issuable upon the vesting of restricted stock units (\"RSUs\") granted on April 30, 2018 under the ReWalk 2014 Equity Incentive Plan. The RSUs vest in four equal quarterly installments starting three months following the date of grant."}],"balance_after":28749,"source":{"system":"sec-edgar","filing":"0001607962-18-000021","document":"wf-form4_152529135234862.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1602327/000160796218000021/wf-form4_152529135234862.xml","form_type":"4"}},{"id":4270170,"issuer":{"id":7620,"kind":"organization","name":"Lifeward Ltd.","symbol":"LFWD"},"owners":[{"id":92148,"kind":"person","name":"Weisman Wayne","position":1,"cik":"0001602327","reported_name":"Weisman Wayne","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Option (Right to buy)","published_at":"2017-06-29T08:12:48.000Z","date":"2017-06-27","kind":"grant","acquired":true,"shares":4176,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents stock options granted under the ReWalk 2014 Equity Incentive Plan on June 27, 2017. The options become vested and exercisable in four equal quarterly installments starting three months following the date of grant."}],"balance_after":4176,"derivative":{"exercise_price":2.1,"expiration_date":"2027-06-27","underlying":"Ordinary Shares, par value NIS 0.01 per share","underlying_shares":4176},"source":{"system":"sec-edgar","filing":"0001628280-17-006789","document":"wf-form4_149873835507102.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1602327/000162828017006789/wf-form4_149873835507102.xml","form_type":"4"}},{"id":4271108,"issuer":{"id":7620,"kind":"organization","name":"Lifeward Ltd.","symbol":"LFWD"},"owners":[{"id":92148,"kind":"person","name":"Weisman Wayne","position":1,"cik":"0001602327","reported_name":"Weisman Wayne","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares, par value NIS 0.01 per share","published_at":"2017-06-28T21:09:13.000Z","date":"2017-06-27","kind":"sale","acquired":false,"shares":49970,"price":3.0931,"value":154562.207,"ownership":{"direct":false,"nature":"By partnership"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 trading plan adopted December 15, 2016."},{"field":"shares","element":"transactionShares","label":"F4","text":"The disposed of securities consist of 37,459 Ordinary Shares sold by SCP Vitalife and 12,511 shares sold by SCP Vitalife Israel."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.0000 to $3.2000, inclusive. The reporting person undertakes to provide to ReWalk Robotics, Ltd. (\"ReWalk\"), any security holder of ReWalk, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (5) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is a director of SCP Vitalife II GP, Ltd. (\"SCP Vitalife GP\"), which is the sole general partner of SCP Vitalife II Associates, L.P. (\"SCP Vitalife Associates\"). SCP Vitalife Associates is the sole general partner of each of SCP Vitalife and SCP Vitalife Israel, the direct beneficial owner of the Ordinary Shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of the Ordinary Shares held by SCP Vitalife and SCP Vitalife Israel, except to the extent of his pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"As of June 27, 2017, SCP Vitalife Associates, as the general partner of SCP Vitalife and SCP Vitalife Israel, may be deemed to beneficially own 1,357,574 Ordinary Shares, which consist of 1,017,674 and 339,900 Ordinary Shares held by SCP Vitalife and SCP Vitalife Israel, respectively. SCP Vitalife GP is the general partner of SCP Vitalife Associates and, as such, shares voting and dispositive power over, and may be deemed to beneficially own, the Ordinary Shares held by the foregoing entities. The Reporting Person shares voting and dispositive power over, and may be deemed to beneficially own 1,500,100 Ordinary Shares, which consist of the Ordinary Shares as set forth in footnote (7) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"As of June 27, 2017, consists of 1,357,574 Ordinary Shares held by the foregoing entities due to the Reporting Person serving as a director of SCP Vitalife GP, as well as (i) 62,006 Ordinary Shares held by Vitalife Partners (Overseas) L.P., (ii) 20,506 Ordinary Shares held by Vitalife Partners (Israel) L.P., (iii) 20,733 Ordinary Shares held by Vitalife Partners (D.C.M) L.P. (\"Vitalife Partners DCM\", and together with Vitalife Partners (Overseas) L.P. and Vitalife Partners (Israel) L.P., the \"Vitalife I Entities\") and (iv) 39,281 Ordinary Shares currently held by the Office of the Chief Scientist of the State of Israel (\"OCS\"), that the Vitalife I Entities have the right to acquire from the OCS, due to the Reporting Person serving as a director of Vitalife Life Sciences Ltd., the general partner of Vitalife Partners Management L.P., which is the general partner of each of the Vitalife I Entities."}],"balance_after":1500100,"source":{"system":"sec-edgar","filing":"0001144204-17-034723","document":"v469957_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1602327/000114420417034723/v469957_form4.xml","form_type":"4"}},{"id":4271107,"issuer":{"id":7620,"kind":"organization","name":"Lifeward Ltd.","symbol":"LFWD"},"owners":[{"id":92148,"kind":"person","name":"Weisman Wayne","position":1,"cik":"0001602327","reported_name":"Weisman Wayne","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares, par value NIS 0.01 per share","published_at":"2017-06-28T21:09:13.000Z","date":"2017-06-26","kind":"sale","acquired":false,"shares":37030,"price":3,"value":111090.0,"ownership":{"direct":false,"nature":"By partnership"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 trading plan adopted December 15, 2016."},{"field":"shares","element":"transactionShares","label":"F2","text":"The disposed of securities consist of 27,759 Ordinary Shares sold by SCP Vitalife Partners II, L.P. (\"SCP Vitalife\") and 9,271 shares sold by SCP Vitalife Partners (Israel) II, L.P. (\"SCP Vitalife Israel\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is a director of SCP Vitalife II GP, Ltd. (\"SCP Vitalife GP\"), which is the sole general partner of SCP Vitalife II Associates, L.P. (\"SCP Vitalife Associates\"). SCP Vitalife Associates is the sole general partner of each of SCP Vitalife and SCP Vitalife Israel, the direct beneficial owner of the Ordinary Shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of the Ordinary Shares held by SCP Vitalife and SCP Vitalife Israel, except to the extent of his pecuniary interest therein."}],"balance_after":1550070,"source":{"system":"sec-edgar","filing":"0001144204-17-034723","document":"v469957_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1602327/000114420417034723/v469957_form4.xml","form_type":"4"}},{"id":4318358,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":92148,"kind":"person","name":"Weisman Wayne","position":1,"cik":"0001602327","reported_name":"Weisman Wayne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-05-16T16:29:33.000Z","date":"2017-05-12","kind":"grant","acquired":true,"shares":13274,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest on May 12, 2018. Vested shares will be delivered to the reporting person within 30 days following the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest on May 12, 2018. Vested shares will be delivered to the reporting person within 30 days following the vesting date."}],"balance_after":13274,"derivative":{"underlying":"Common Stock","underlying_shares":13274},"source":{"system":"sec-edgar","filing":"0001123292-17-000942","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1602327/000112329217000942/edgar.xml","form_type":"4"}},{"id":4517055,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":92148,"kind":"person","name":"Weisman Wayne","position":1,"cik":"0001602327","reported_name":"Weisman Wayne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-12-19T16:28:07.000Z","date":"2016-12-16","kind":"purchase","acquired":true,"shares":3000,"price":6.57,"value":19710.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.55 to $6.61, inclusive. The reporting person undertakes to provide to Recro Pharma, Inc., any security holder of Recro Pharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":7000,"source":{"system":"sec-edgar","filing":"0001123292-16-003077","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1602327/000112329216003077/edgar.xml","form_type":"4"}},{"id":4517054,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":92148,"kind":"person","name":"Weisman Wayne","position":1,"cik":"0001602327","reported_name":"Weisman Wayne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-12-19T16:28:07.000Z","date":"2016-12-15","kind":"purchase","acquired":true,"shares":4000,"price":6.53,"value":26120.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.50 to $6.55, inclusive. The reporting person undertakes to provide to Recro Pharma, Inc., any security holder of Recro Pharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":4000,"source":{"system":"sec-edgar","filing":"0001123292-16-003077","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1602327/000112329216003077/edgar.xml","form_type":"4"}}]}